The Online Investor
Diagnostics M&A image Diagnostics M&A » By The Online Investor Staff, updated Fri., Mar. 29, 11:48 AM Recent mergers and acquisitions in the Diagnostics M&A category.

Slide #48. Clinical Genomics Technologies Pty Ltd Quest Diagnostics Enterix colorectal cancer screening test business

Acquirer: Clinical Genomics Technologies Pty Ltd
Acquiree: Quest Diagnostics Enterix colorectal cancer screening test business (NYSE:DGX)
Details: Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that on September 30, 2013 it completed the sale of its Enterix colorectal cancer screening test business to Clinical Genomics Technologies Pty Ltd., an Australian life sciences company. Terms of the transaction were not disclosed.



Open the DGX Page at The Online Investor »

Company Name: 
Quest Diagnostics, Inc.
Stock buyback: 
DGX buyback
Website: 
www.QuestDiagnostics.com
Sector: 
Diagnostics
Number of ETFs Holding DGX: 
112
Total Market Value Held by ETFs: 
$2.77B
Total Market Capitalization: 
$14.51B
% of Market Cap. Held by ETFs: 
19.07%
 

Open the DGX Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree DGX Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (2.53 out of 4)
6th percentile
(ranked lower than approx. 94% of all stocks covered)

Analysts' Target Price:
DGX Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Diagnostics M&A - Slide 48 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.